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on a background of slowly progressive deterioration of mobility, personality,
and intellect.
Neurological investigation included computed tomography, which showed
cortical atrophy, and a non-specifically abnormal electroencephalograph, with
much high voltage fi activity. Random estimations of blood glucose concentra-
tions were consistently normal except for one subnormal result in 1976 when it
was thought that she had accidentally taken sulphonylurea tablets. Subsequent
random blood glucose estimations were normal and this was not investigated
further.
Inappropriate insulin secretion was confirmed by finding serum insulin
concentrations of9-3 and 10-2 mU/l during subsequent hypoglycaemic episodes.3
Further episodes were effectively prevented by oral diazoxide. While undergoing
investigation, however, she developed rapidly fatal septicaemia. At postmortem
examination a well differentiated islet cell tumour, 15 mm in diameter, was found
in the pancreas. Her brain was atrophic, and histological examination showed
multiple focal infarcts of variable size in the cerebral and cerebellar hemispheres
and basal ganglia, with relative sparing of the temporal lobes and hippocampus.
In the cerebellum there was widespread loss of Purkinje cells.
Comment
An insidious and irreversible dementing process without acute episodes
has been described with insulinoma but is rare; two major reviews of a total
of 318 cases found evidence of irreversible neuropsychiatric deficit in only
three cases.24 The duration ofsymptoms before diagnosing insulinoma often
exceeded 10 years,' and one well documented case presented with a history
of over 25 years.5 Such a delay in diagnosis is presumably more likely when
the course is atypical or relatively benign.
We suggest that our patient's gradual global neurological deterioration
since adolescence was the result of recurrent episodes of hypoglycaemia
due to an insulinoma that had eluded diagnosis for over 30 years. This case
illustrates the difficulty of detecting intermittent hypoglycaemia and the
importance ofexcluding it with fasting blood samples in cases ofprogressive,
unexplained neurological deficit.
1 Marks V, Samols E. Insulinoma: natural history and diagnosis. Clinics tn Gastroenterology
1974;3:559-73.
2 Crain EL, Thorn GW. Functioning pancreatic islets cell adenomas. Medicine (Baltimore)
1949;28:42747.
3 Turner RC, Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests
for insulinomas. Diabetologia 1977;13:571-7.
4 Service FJ, Dale AJD, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features ofsixty
consecutive cases. Mayo Clin Proc 1976;51:417-29.
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Predicting risk of diabetic ketoacidosis in
patients using continuous subcutaneous
insuln inusion
Several recent reports have discussed an increased incidence of diabetic
ketoacidosis during continuous subcutaneous insulin infusion compared
with conventional injection treatment. 1-3 The possibility that this increased
incidence may be at least partly due to certain characteristics of the patients
who use infusion treatment has not previously been explored.
Patients, methods, and results
During a feasibility study of the use of continuous subcutaneous insulin
infusion in a diabetes clinic 11 patients were identified who had experienced
episodes of diabetic ketoacidosis over a period of two years and six months while
using the infusion treatment.4 These patients were matched for age, sex, and
duration of diabetes with 11 patients using continuous subcutaneous infusion
who had not experienced ketoacidosis. All 22 patients had completed a series of
newly designed psychological scales before starting the treatment. The psycho-
metric development of these scales has been described elsewhere.5 Ketoacidosis
was defined as ketosis and hyperglycaemia with thirst, nausea, malaise and
vomiting, and plasma bicarbonate concentration <15 mmol(mEq)/l.
The groups were compared for age at leaving full time education, daily insulin
dosage and carbohydrate intake, duration of insulin use, initial and 12 monthly
glycosylated haemoglobin concentrations and psychological measures. The
psychological scales provided measures of perceived control of diabetes, which
included five scales measuring internal versus external control and two scales
measuring perceptions of medical factors affecting control. Scales measuring
health beliefs specific to diabetes provided eight further variables. Independent
group t tests were used for comparison between the two groups on all measures.
The table shows the results.
Comparison of demographic, clinical, and psychological variables in patients who
suffered episodes ofketoacidosis and those who did not. Values are means (SD)
Did not
Developed develop
ketoacidosis ketoacidosis t df p
Demographic features
Sex 7F:4M 7F:4M
Age(years) 35-2(13-8) 340(13-1) -0-21 20 NS
Ageatleavingfulltimeeducation 15-4(1-3) 18 5 (3-6) 2-29 17 <0 05
Clinical and biochemicalfeatures
Durationofdiabetes(years) 13-9(10-8) 14 2(10-0) 0-06 20 NS
Dailyinsulindosage(U/kg) 55-8(21-5) 61 0(19 7) 010 20 NS
Glycosylated haemoglobin (%):
Initially 60 4 (9-2) 58-5 (12-2) -0 39 20 NS
At 12months 51-2 (6-9) 52 3 (7-8) 0-32 18 NS
Psychologicalfeatures
Perceived control scales*:
Internality 23-9 (7-0) 25-1 (4-3) 0-47 17 NS
Personal control 22-8 (4-6) 27-7 (2-2) 2-98 16 <0-01
Foreseeability 17-9 (4-4) 24-2 (8-5) 1-92 17 0-071
Externality 12-1 (7-4) 10-2 (6-5) -0 61 17 NS
Chance 12-7 (6-5) 11-1 (7-1) -0-51 18 NS
Treatment 18-1 (4-0) 13-9 (4-5) -2-09 17 0-052
Medical control 14 3 (6-3) 13-3 (7-4) -0-30 17 NS
Health belief scales:
Perceived severityt:
Hypoglycaemia 3-4 (1-2) 4-4 (1-3) 1-88 20 0-075
Hyperglycaemic coma 5-4 (0-7) 5-5 (0-5) 0-71 20 NS
Perceived vulnerabilityt:
Hypoglycaemia 5-0 (1-2) 4 4 (1-9) -0-% 20 NS
Hyperglycaemic coma 4-2 (1-2) 2-9 (1-2) -2-50 20 <0-05
Perceived severity of complicationst 20-7 (1-4) -21-1 (2-0) 0-49 20 NS
Perceived vulnerability to complicationst 15-0 (3-6) 15-4 (3-5) 0-24 20 NS
Perceived benefits of treatmentS 26-1 (7-2) 28-8 (6-2) 0-95 20 NS
Perceived barriers to treatment§ 16-5 (8-4) 12-0 (5-9) -1-44 20 NS
*Scores ranged from 0 to 36: the higher the score the stronger the attribution towards the
variable.
tScores ranged from 1 to 6: the higher the score the greater the perceived severity or
vulnerability.
tScores ranged from 4 to 24: the higher the score the greater the perceived severity or
vulnerability.
5Scores ranged from 0 to 36: the higher the score the more benefits or barriers perceived.
Clinical and demographic measures did not differ between the groups, except
for age at leaving full time education: patients who developed ketoacidosis had
had significantly fewer years of full time education.
Psychological measures-Significant or nearly significant differences were
obtained for three of the seven scales measuring perceived control-namely,
personal control, foreseeability, and treatment. Compared with the patients who
had not experienced episodes ofketoacidosis, those who had felt less personally in
control of their diabetes, thought that outcomes were less foreseeable, and
attributed more responsibility for diabetes management to the treatment. The
health belief ratings indicated that patients who had had episodes of ketoacidosis
tended to feel more vulnerable to problems related to their diabetes, differences
between groups reaching significance for perceived vulnerability to hyper-
glycaemic coma. None of the differences in ratings of perceived severity of
complications reached significance, although the patients who had had episodes
of ketoacidosis tended to rate each problem as less severe.
Comment
The two groups of patients were distinguishable only by the psychological
variables measured and age at leaving full time education, the patients who
developed ketoacidosis having had fewer years of education. These patients
seemed to be looking for a medical solution to their diabetes and considered
that they personally had little control over the disease. Such patients may be
less likely to detect metabolic problems and to initiate emergency action
when necessary. Before using continuous infusion treatment the patients'
who went on to develop ketoacidosis rated themselves as being more
vulnerable to this complication, although prior experience of ketoacidosis
was similar in both groups. These feelings ofvulnerability might reflect their
feelings of being less in control of their diabetes.
Over optimistic expectations of continuous subcutaneous infusion may
have encouraged patients to assume that less personal responsibility for their
diabetes would be required than with injection treatment. Ketoacidosis
may, however, have arisen because of some characteristic of infusion
treatment combined with the psychological characteristics identified here.
Either way, this study indicates that patients' perceptions of their vulner-
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ability to ketoacidosis and their more general perceptions of control of
diabetes provided useful pointers to risks of subsequent ketoacidosis during
use of continuous subcutaneous infusion.
1 Mecklenberg RS, Benson EA, Benson JW, et al. Acute complications associated with insulin
infusion pump therapy. Report of experience with 161 patients.JAMA 1984;252:3265-9.
2 Peden NR, Braaten JT, McKendry JBR. Diabetic ketoacidosis during long-term treatment with
continuous subcutaneous insulin infusion. Diabetes Care 1984;7:1-5.
3 Knight G, Jennings AM, Boulton AJM, Tomlinson S, Ward JD. Severe hyperkalsenia and
ketoacidosis during routine treatment with an insulin pump. BrMedJ 1985;291:371-2.
4 Knight G, Boulton AJM, Drury J, et al. A feasibility study of the use of continuous subcutaneous
insulin infusion in a diabetic clinic: patients' choice of treatment. Diabeic Medicine 1984;1:267-
72.
5 Bradley C, Brewin CR, Gamsu DS, Moses JL. Development ofscales to measure perceived control
of diabetes mellitus and diabetes-related health beliefs. DiabeticMedicine 1984;1:213-8.
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Spontaneous,pneumomediastinum in two
stowaways
We describe two cases ofpneumomediastinum which occurred in stowaways
on a banana boat arriving at Avonmouth Docks, Bristol, from Columbia,
South America. The voyage took 17 days, duringwhich time the twomen ate
and drnk very little. The temperature in the hold of the ship was 54-59CC.
Case reports
Case I-A 23 year old msn was hypothermic (34-r8C), moderately dehydrated,
and, except for resting tachycardia of% beats/min, showed no abnormal cardio-
vascular or respiratory signs. There was evidence of cold injury to both feet.
Investigations showed blood urea concentrations of 76 mmol/l (458 mg/100 ml),
creatinine 475 Fmol/l (5-4 mg/100 ml), sodium 155 mmol(mEqcil, chloride 105
mmol(mEq)/l, bicarbonate 21 mmol(mEq)/l, and potassium 44'mmol(mEq)/l.
Concentration of urinary sodium was 28 mmol/l and urea 401 rnmolfl (2-4 g/100
ml), indicating dehydration-with prerenal uracmia and no metabolic acidosis.
Biochemical values returned to normal when the patient was rehydrated. The
patient complained of chest pain, worsened by breathing and recumbency.
Despite the absence of physical signs in the chest a radiograph showed
mediastinal and soft tissue emphysema. This resolved within five days. He was
found to be infested with Ascans lumbricoides.
Case 2-A 19 year old man was also hypothermic (35-2°C) and moderately
dehydrated with a resting tachycardia,of 100 beats/min. There were no other'
abnormal physical signs. The blood urea concentration was 44-5 mmol/l (268 mg/
100 ml), creainine 171 pmol/l (1-9 mg/100 ml), sodium 152 mmol/l,,chloride 105
mmol/l, bicarbonate 25 mmol/l, and potassium 3-7 mmol/l. Urinary sodium
concentration was 7 mmol/l and urea 696 mmol/1 (42 g/100 ml), which again
confirmed dehydration with prerenal uraemia but no metaboic acidosis. These
measures became normal when the patient was rehydrated. Routine chest
radiography showed emphysema of the mediastinum and chest wall. There were
no symptoms or signs, however, of either of these conditions. Resolution
occurred within five days. He was infested with Trichuris vtichuria, Necator
amencanus, and Strongyloides stercoratis.
Comment
Air reaching the mediastinum from the interstitial tissues of the lungs
results from rupture ofmarginal alveolar bases and may occurwhen there is a
sudden rise of intra-alveolar pressure. The pathophysiological mechanism
that results in interstitial air in cases of asthma has been elucidated by
Mackiln and Mackhln.' They found that bronchospasm, mucosal oedema,
and inspissation ofsecretion$ in people with asthma caused air to be trapped
with resulting stretching of alveoli. Supporting structures such as the
pulmonary arteries, veins, and alveolar septa have limiited elasticity, and as
distension increases shearing forces, developed by ex.aggerated respiratory
effort, rupture the marginal alveolar bases. T!he escaping air dissects along
the perivascular sheaths towards the hilum.
Similar mechaniss have been postul.ated in pneumomediastinum associ-
ated with artificial ventilation, parturition, strenuous exercise, and diabetic
ketosis. In diabetic ketosis the rise in intra-alveolar pressure is thought to be
a result of repeated vomiting. This is also thought to cause some cases of
pneumomediastinum in patients with anorexia nervosa. Pneumomedia-
stinum, however, has been reported in the absence ofvomiting in a girl with
anorexia nervosa and in an emaciated adolescent boy with functional
anorexia of a month's duration.23 Experimental work on rats' lungs has
shown that an inadequate diet, by decreasing tissue elasticity and increasing
surface forces, may result in air trapping owing to premature closure of the
airway.4 Microscopic examination of these lungs showed a decrease in the
volume density of lamellar bodies, mitochondria, and cytoplasm. As the
granular pneumocyte lamellar bodies are the site of surfactant storage, its
reduction may partly account for the altered mechanics, and hence a cellular
cause for the raised intra-alveolar pressure is possible.
The possibility that similar changes might occur during starvation and
account for pneumomediastinum in patients with anorexia nervosa where
vomiting is not a factor has previously been considered.34 These
stowaways had been in the ship's hold for nearly three weeks with very little
food or water. Their diet before this was possibly poor, and, moreover, both
were infested with intestinal worms. The mechanism of pneumomedia-
stinum in their cases might be similar to that postulated in some patients
with anorexia nervosa.
I MackIn MT, Macllin CC. Malignant intersttial emphysema of lungs and mediastinum as
important occult complications in many respiratory diseases and other conditions: interpretation
of clinical literature in the light of laboratory experiment. Medicin 1944;23:281-358.
2 Donley AJ, Kemple TJ. Spontaneous pneunitinum complicating anorexia nervosa. Br
MedJ 1978;iv: 1604-5.
3 Al-Mufty NS, Bevan DH. A case of subcutaneous emphysema, pneumomediasinum and
pnumopentom associated with functionl anorexia. Br7 Clu Pract 1977;31:160- 1.
4 Sahebiame H, Vsallo CL, Wirman JA. Lung mechanics and ultrasucture in prolnged
starvation. Ax Joumnal ofRespusoy Diseases 1975;117:77-83.
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Life threateng reaction to tuberculin
testing
Severe anaphylactoid reactions after tuberculin testing are rarely seen
nowadays. We report on a patient who developed an acute severe systemic
upset with renal failure and hepatic dysfunction after an intradermal
injection of 0-1 ml tuberculin purified protein derivative at a 1:10 000
dilution (1 IU).
Case report
A 35 year old Portuguese woman, who-had lived in England for 14 years,
presented with a two month history of cervical lymphadenopathy. She was
otherwise well. Histological examination of a lymph node biopsy specimesi had
shown epitheloid granulomata but no acid fast bacilli on Ziehl-Neelsen staining;
the tissue was set up for culture. All initial investigations, including renal and
hepatic function, were normal. A 0-1 ml sample of a 1:10 000 (1 IU) diluted
tuberculin purified protein derivative was given intradermally in the right
forearm. Within three hours of this iplection she developed a feve, with rigors,
sweaiing, and profse vomiting; over the next 48 hours her condition deteriorated
with generalised aches and pains, dry cough, and oliguria. On admission tot
hospital she was feverish (39°C) with a low volume-tachycardia (120 beats/minute)
and a blood pressure of 70/40 mm Hg. There was no reaction at the site of the
tuberculin injection.
Investigations showed a white cell count of 9x 1061/1 with normal differential;
concentrations of urea 24-3 mmol/k (normal range 3-0-6-5 mmol/l) (146 mg/100
ml (18-39 mg/100 nl)). sodium 130 mmol (mEq)/l (135-45-mmol (mEq)/l),
potassium 3-4 mmol (mEq)/l (3-5-5-0 mmol (mEq)/l), and total bilirubin 45
pmol/ (5-17 pmol/1) (2-7.mg) 100 ml (0-3-1-0 mg/100 ml)); activities of aspartstetransamiawse 117 IU/I (5-40 IU/l) and alkalinephosphatase 207 IU/l(35-130 IU/I);
concentration of total protein 64Al (60-80 g/l) wi-h an albumn concentration of
36 g/l (30-50 g/l)i prothrombin time 17 seconds (11-14 seonds) and partial
thromboplastin time 43 seconds (30-40 seconds) but no fibrinogen degradation
products. The patient's urinary volume was less than2 ml/hour,;a24 hour urinary
collection showed a total protein- concentration of 1-20 g/l (0-05), sodium
concentration 62 mmol/l (100-250 mmol/l), potassium concentration 45 mmol/l(40-120Ommolfl)and ureaconcentration 183 mmol/l(170-600mmol/l(1-1 (1-0-3-6
